Omalizumab Reduces Exacerbations in Allergic Bronchopulmonary Aspergillosis
Colby Stong Omalizumab resulted in significantly lowered OCS use in 65% of patients with ABPA and eliminated OCS use in 53% of patients. Omalizumab was associated with a significant decrease…